FDA Approves Oral Lacosamide (Vimpat) for Children With Epilepsy FDA Approves Oral Lacosamide (Vimpat) for Children With Epilepsy

The FDA expands the indication for the antiepileptic lacosamide to children as young as age 4 years with partial-onset seizures.FDA Approvals
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Neurology & Neurosurgery News Alert Source Type: news